Protect Pharmaceutical Stock Debt To Equity
| PRTT Stock | USD 0.89 0.01 1.11% |
Protect Pharmaceutical fundamentals help investors to digest information that contributes to Protect Pharmaceutical's financial success or failures. It also enables traders to predict the movement of Protect Pink Sheet. The fundamental analysis module provides a way to measure Protect Pharmaceutical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Protect Pharmaceutical pink sheet.
Protect |
Protect Pharmaceutical Company Debt To Equity Analysis
Protect Pharmaceutical's Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
| Competition |
According to the company disclosure, Protect Pharmaceutical has a Debt To Equity of 0.0%. This is 100.0% lower than that of the Pharmaceuticals sector and 100.0% lower than that of the Health Care industry. The debt to equity for all United States stocks is 100.0% higher than that of the company.
Protect Debt To Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Protect Pharmaceutical's direct or indirect competition against its Debt To Equity to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Protect Pharmaceutical could also be used in its relative valuation, which is a method of valuing Protect Pharmaceutical by comparing valuation metrics of similar companies.Protect Pharmaceutical is currently under evaluation in debt to equity category among its peers.
Protect Fundamentals
| Current Valuation | 2.6 M | |||
| Shares Outstanding | 1.11 M | |||
| Shares Owned By Insiders | 84.30 % | |||
| Price To Earning | (23.96) X | |||
| EBITDA | (115.4 K) | |||
| Net Income | (122.61 K) | |||
| Cash And Equivalents | 20.07 K | |||
| Total Debt | 101 K | |||
| Current Ratio | 0.40 X | |||
| Book Value Per Share | (0.01) X | |||
| Earnings Per Share | (0.02) X | |||
| Number Of Employees | 11 | |||
| Beta | 2.38 | |||
| Market Capitalization | 2.5 M | |||
| Retained Earnings | (9.37 M) | |||
| Working Capital | (33 K) | |||
| Current Liabilities | 33 K | |||
| Z Score | 14.4 |
About Protect Pharmaceutical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Protect Pharmaceutical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Protect Pharmaceutical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Protect Pharmaceutical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Protect Pink Sheet Analysis
When running Protect Pharmaceutical's price analysis, check to measure Protect Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protect Pharmaceutical is operating at the current time. Most of Protect Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Protect Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protect Pharmaceutical's price. Additionally, you may evaluate how the addition of Protect Pharmaceutical to your portfolios can decrease your overall portfolio volatility.